About
Contact
Subscribe
e-Edition

Make Home Page

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook
Twitter

- Site search

Home
News
Sports
- Local Sports
- National Sports
Business
Opinion
A & E
Life
Features & Magazines
Classifieds
Weather
Obituaries
Parcel Pickup

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Nurix Therapeutics, Inc. - Common stock (NQ:NRIX)

18.86 +0.37 (+2.00%)

Streaming Delayed Price Updated: 3:45 PM EST, Jan 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Nurix Therapeutics, Inc. - Common stock

< Previous 1 2 3 4 5 Next >

Bit Digital, Cipher Mining And Other Big Stocks Moving Higher In Thursday's Pre-Market Session ↗

December 28, 2023

U.S. stock futures were mixed this morning, with the Dow Jones futures falling around 40 points on Thursday. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

Topics Stocks

Judith A. Reinsdorf and Katherine M. Sandstrom Named to Toll Brothers Board of Directors

December 13, 2023

From Toll Brothers, Inc.

Via GlobeNewswire

10 Health Care Stocks With Whale Alerts In Today's Session ↗

December 11, 2023

Via Benzinga

The Latest Analyst Ratings for Nurix Therapeutics ↗

October 13, 2023

Via Benzinga

What 4 Analyst Ratings Have To Say About Nurix Therapeutics ↗

September 07, 2023

Via Benzinga

Analyst Ratings for Nurix Therapeutics ↗

July 24, 2023

Via Benzinga

Nurix Therapeutics's Return On Capital Employed Insights ↗

July 14, 2023

Via Benzinga

Cathie Wood-Led Ark Invest Sells Over $6.5M Worth Of Tesla Stock, What's Going On? ↗

October 17, 2023

Via Benzinga

Why Is Cancer Focused Nurix Therapeutics Stock Trading Higher Today? ↗

September 07, 2023

Nurix Therapeutics Inc (NASDAQ: NRIX) has entered into a multi-year, multi-target strategic collaboration agreement with Seagen Inc (NASDAQ: SGEN) to advance a new class of medicines called...

Via Benzinga

Designer Brands, Calavo Growers, Couchbase And Other Big Stocks Moving Higher On Thursday ↗

September 07, 2023

U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 200 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Analyst Cuts Nurix Therapeutics Price Target By 38%, Cites Lymphoma Data ↗

July 24, 2023

HC Wainwright analyst Robert Burns has lowered the price target for Nurix Therapeutics Inc (NASDAQ: NRIX)

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

July 14, 2023

It's time to start the final trading day of the week with a breakdown of the biggest pre-market stock movers for Friday!

Via InvestorPlace

Analyst Ratings for Nurix Therapeutics ↗

April 14, 2023

Via Benzinga

Nurix Therapeutics Inc. (NASDAQ: NRIX) Highlighted for Surprising Price Action

April 13, 2023

Via Investor Brand Network

JPMorgan, Citigroup, QuidelOrtho And Other Big Stocks Moving Higher On Friday ↗

April 14, 2023

U.S. stocks traded lower, with the Dow Jones dropping over 150 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Expert Ratings for Nurix Therapeutics ↗

March 21, 2023

Via Benzinga

Gilead Exercises First License Option Under Agreement With Nurix Therapeutics ↗

March 20, 2023

Via Benzinga

Gilead Exercises Option to License Nurix’s IRAK4 Targeted Protein Degrader Development Candidate, NX-0479

March 20, 2023

From Gilead Sciences, Inc.

Via Business Wire

Analyst Ratings for Nurix Therapeutics ↗

February 28, 2023

Via Benzinga

Nurix Therapeutics's Return On Capital Employed Overview ↗

February 14, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 9, 2023 ↗

March 09, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 28, 2023 ↗

February 28, 2023

Via Benzinga

The Top 5 Stocks Cathie Wood Bought and Sold This Week ↗

October 21, 2022

Cathie Wood's flagship ETF, the ARK Innovation ETF, hit a five-year and 52-week low this week, casting doubts on the investment manager.

Via InvestorPlace

CSX, Veris Residential And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

October 21, 2022

U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2022 ↗

October 11, 2022

Upgrades

Via Benzinga

Cathie Wood Loads Up Over $6.7M In Adobe Stock As It Tumbles 27% In A Month — Also Adds Stake In This Biopharma Company ↗

October 10, 2022

Cathie Wood-led ARK Investment Management bought over 23,000 shares of software maker Adobe Inc (NASDAQ: ADBE) through the

Via Benzinga

Why SOBR Safe Shares Surged Around 233%; Here Are 68 Biggest Movers From Yesterday ↗

September 21, 2022

Gainers

Via Benzinga

Top Russell 2000 Stocks: Trading Opportunities For Next Week - Sunday, Sept. 11 ↗

September 11, 2022

A security pattern traces the distinct movements of security prices that, once recognized, help traders to make informed trading decisions. Here is a closer look at some Russell 2000 stock...

Via Talk Markets

Tesla, Twitter And 76 Biggest Movers From Friday ↗

July 11, 2022

Gainers Seritage Growth Properties (NYSE: SRG) shares surged 80.3% to settle at $10.96 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board...

Via Benzinga

Why Nurix Therapeutics Shares Are Rising Today ↗

July 08, 2022

Nurix Therapeutics Inc (NASDAQ: NRIX) shares are trading higher by 13.25% to $17.52 Friday afternoon after the company announced a registered direct offering for total gross proceeds of approximately...

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Opinion
Photo Galleries
Videos
Local Events
Classifieds
Obituaries

Services

About
Contact
Personnel
Advertise
Subscription Services
Promote Your Event
Dealer Locations
Email Alerts
Submission Forms

Contact Information

chroniclejournal.com
75 S. Cumberland Street
Thunder Bay, ON P7B 1A3
Phone: 807 343 6200
Email: circulation@chroniclejournal.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Nurix Therapeutics, Inc. - Common stock (NQ:NRIX)

All News about Nurix Therapeutics, Inc. - Common stock

Sections

Services

Contact Information

Follow Us